Quanta Matrix Inc., a global personalized diagnostics company founded in 2010 and located in Seoul, Korea, is committed to improving the quality of decision making process in patient specific medication for infectious disease and cancer. The company commercializes molecular and cellular diagnostic service enabled by proprietary instrumentations and disposable kits developed in-house.